Table: Wakamoto Pharm - 6-MTH parent results
Nov 4 (Reuters)-
Wakamoto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4.01 4.28 9.10
(-20.4 pct)
Operating loss 172 mln loss 617 mln 60 mln
Recurring loss 153 mln loss 540 mln 80 mln
Net 111 mln loss 632 mln 290 mln
EPS 3.22 yen loss 18.22 yen 8.36 yen
Ann Div NIL
-Q2 div NIL NIL
-Q4 div NIL
NOTE - Wakamoto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T